Trial Profile
Research for the role of the action of GLP-1 on normal glucose tolerance
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2019
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 16 Sep 2016 Status changed from not yet recruiting to completed.
- 09 Dec 2011 New trial record